Last update 06 Dec 2024

CAStem Cell (Beijing Zehui Chenxing)

Overview

Basic Info

Drug Type
Stem cell therapy
Synonyms
人胚干细胞（hESC）（北京泽辉辰星）, ZH901
Target-
Mechanism
Cell replacements
Therapeutic Areas
Immune System DiseasesRespiratory DiseasesOther Diseases+ [1]
Active Indication
Acute Graft Versus Host DiseaseLung Diseases, InterstitialRespiratory Distress Syndrome, Acute+ [2]
Inactive Indication-
Originator Organization
Beijing Zehui Chenxing Biotechnology Co., Ltd.Beijing Zehui Chenxing Biotechnology Co., Ltd.
Active Organization
Beijing Zehui Chenxing Biotechnology Co., Ltd.Beijing Zehui Chenxing Biotechnology Co., Ltd.Institute of Zoology Chinese Academy of ScienceInstitute of Zoology Chinese Academy of Science
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

6
Clinical Trials associated with CAStem Cell (Beijing Zehui Chenxing)
ChiCTR2300077942 / RecruitingPhase 2IIT
Efficacy and safety of CAStem cell injection in treatment of acute graft-versus-host disease
ChiCTR2400081256 / RecruitingPhase 2IIT
Efficacy and safety of CAStem cell injection in the treatment of acute exacerbation of interstitial lung disease (AE-ILD)
CTR20231881 / RecruitingPhase 2
CAStem细胞注射液治疗间质性肺疾病急性加重
[Translation] CAStem cell injection for the treatment of acute exacerbation of interstitial lung disease
100 Clinical Results associated with CAStem Cell (Beijing Zehui Chenxing)
Login to view more data
100 Translational Medicine associated with CAStem Cell (Beijing Zehui Chenxing)
Login to view more data
100 Patents (Medical) associated with CAStem Cell (Beijing Zehui Chenxing)
Login to view more data
100 Deals associated with CAStem Cell (Beijing Zehui Chenxing)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute Graft Versus Host DiseasePhase 2
CN
Beijing Zehui Chenxing Biotechnology Co., Ltd.Beijing Zehui Chenxing Biotechnology Co., Ltd.
18 Jan 2024
Lung Diseases, InterstitialPhase 2
CN
Beijing Zehui Chenxing Biotechnology Co., Ltd.Beijing Zehui Chenxing Biotechnology Co., Ltd.
21 Sep 2023
Respiratory Distress Syndrome, AcutePhase 2
CN
Beijing Zehui Chenxing Biotechnology Co., Ltd.Beijing Zehui Chenxing Biotechnology Co., Ltd.
10 Dec 2022
Meniscus disorderPhase 2
CN
Beijing Zehui Chenxing Biotechnology Co., Ltd.Beijing Zehui Chenxing Biotechnology Co., Ltd.
04 Mar 2022
Meniscus disorderPhase 2
CN
Institute of Zoology Chinese Academy of ScienceInstitute of Zoology Chinese Academy of Science
04 Mar 2022
Respiratory Distress Syndrome, AdultIND Approval
CN
Beijing Zehui Chenxing Biotechnology Co., Ltd.Beijing Zehui Chenxing Biotechnology Co., Ltd.
14 Feb 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free